home / stock / biovf / biovf news


BIOVF News and Press, Swedish Orphan Biovit Ord

Stock Information

Company Name: Swedish Orphan Biovit Ord
Stock Symbol: BIOVF
Market: OTC

Menu

BIOVF BIOVF Quote BIOVF Short BIOVF News BIOVF Articles BIOVF Message Board
Get BIOVF Alerts

News, Short Squeeze, Breakout and More Instantly...

BIOVF - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2024 Earnings Call Transcript

2024-07-16 12:20:29 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2024 Earnings Conference Call July 16, 2024, 08:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Lydia Abad-Franch - Head, R&D...

BIOVF - Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting

WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...

BIOVF - Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome

WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...

BIOVF - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2024 Earnings Call Transcript

2024-04-25 16:12:02 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2024 Earnings Conference Call April 25, 2024 10:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Lydia Abad-Franch - Head of R&...

BIOVF - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

BIOVF - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2023 Earnings Call Transcript

2024-02-08 14:21:03 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2023 Results Conference Call February 08, 2024 08:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Lydia Abad-Franch - Head of R&a...

BIOVF - Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.21, revenue of SEK6.84B

2024-02-08 06:11:24 ET More on Swedish Orphan Biovitrum AB Historical earnings data for Swedish Orphan Biovitrum AB Financial information for Swedish Orphan Biovitrum AB Read the full article on Seeking Alpha For further details see: Swedish Orphan Biovit...

BIOVF - First RSV shots, groundbreaking gene therapy among 2024 drugs to watch

2024-01-14 12:00:24 ET More on CRISPR, GSK, etc. Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry CRISPR Therapeutics AG (CRSP) 42nd Annual J.P. Morgan Healthcare Conference (Transcript) ...

BIOVF - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2023 Earnings Call Transcript

2023-10-30 14:39:02 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2023 Earnings Conference Call October 30, 2023, 8:00 a.m. ET Company Participants Guido Oelkers - CEO Henrik Stenqvist - CFO Lydia Abad-Franch - Head of R&D and Chief Medical Officer Arm...

BIOVF - Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK0.54, revenue of SEK5.17B

2023-10-30 12:17:25 ET More on Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB (publ) 2023 Q3 - Results - Earnings Call Presentation Apellis extends selloff as JPMorgan becomes latest to downgrade Historical earnings data for Swedish Orphan Biovitrum AB ...

Next 10